Christopher J. Reinhard
Executive Chairman of the Board of Directors

     Christopher J. Reinhard has been our Executive Chairman of the Board of Directors since June 2004. Since December 2003, Mr. Reinhard has also served as Chairman of the Board and Chief Executive Officer of Cardium Therapeutics, Inc., a public biotechnology company. From July 2002 to December 2004, Mr. Reinhard served as Chief Executive Officer of Collateral Therapeutics, Inc., a public biotechnology company. Prior to the acquisition of Collateral Therapeutics, Inc. by Schering AG in July 2002, Mr. Reinhard worked for Collateral Therapeutics in a variety of roles from June 1995 to July 2002, including Chief Financial Officer and President. Mr. Reinhard holds a B.S. in Finance and an M.B.A. from Babson College. 

Michael K. Green
Chief Financial Officer

    Michael K. Green has been our Chief Financial Officer since May 2008. From October 2003 to May 2008, Mr. Green was employed with Orchestra Therapeutics, Inc., a publicly traded immuno-pharmaceutical company, most recently serving as the Chief Operating Officer and Chief Financial Officer. From May 1991 to September 2002, he served as Senior Vice President and Chief Financial Officer of Synbiotics Corporation, a publicly traded animal health company. Prior to that, he was Chief Financial Officer of Immunopharmaceutics Inc., a human pharmaceutical company, from May 1991 to October 1993. Before that, Mr. Green spent 13 years with Price Waterhouse in various offices in the United States and Australia. Mr. Green holds a Bachelor of Business Studies degree from the New South Wales Institute of Technology in Sydney, Australia.

Karla R. Kelly, J.D.
Chief Legal Officer, General Counsel and Corporate Secretary

      Karla R. Kelly, J.D. has been our Chief Legal Officer since June 2006. Prior to that, she was our Vice President, Legal Affairs from December 2005 to June 2006. She also has been our General Counsel and Corporate Secretary since December 2005. Ms. Kelly has provided legal services to us since 1999. Prior to joining us, Ms. Kelly practiced out of her own law firm, Karla R. Kelly, a Professional Law Corporation, from February 2003 to December 2005. From August 1998 to January 2003, Ms. Kelly practiced as Special Counsel with the law firm of Luce Forward Hamilton & Scripps LLP in San Diego, California. Ms. Kelly holds a B.A. in Nursing from the College of St. Catherine and a J.D. from the George Washington University National Law Center.

Greg J. Kricorian, M.D.
Chief Medical Officer

      Greg J. Kricorian, M.D. has been our Chief Medical Officer since July 2007. Before Artes Medical, he served as Senior Director, Medical Affairs for Valeant Pharmaceuticals International, a leading global specialty pharmaceutical company.  Previously, Dr. Kricorian held positions in Medical Affairs at ICN Pharmaceuticals (now Valeant), and prior to that was a practicing Dermatologist focusing on aesthetic procedures, including dermal fillers. Dr. Kricorian is a Board Certified Dermatologist and holds a B.S. in Biology from University of California, Los Angeles; an M.D. degree from Stanford University Medical School; and an M.B.A. degree from the University of California, Los Angeles.

Larry J. Braga
Vice President, Manufacturing

     Larry J. Braga has been our Vice President, Manufacturing since June 2005 and previously served as Senior Director, Collagen Manufacturing since June 2004. From April 2000 to May 2004, he served as Director of Manufacturing at Anosys, Inc., a privately held vaccine development company. From November 1997 to April 2000, Mr. Braga served as Senior Process Engineer at Cohesion Technologies Inc., a public medical device company. Mr. Braga holds a B.S. in biological sciences from California State University in Hayward. He also holds a California pharmacy exemptee license.

Susan A. Brodsky-Thalken
Vice President, U. S. Sales and Training

      Susan A. Brodsky-Thalken has been our Vice President, U. S. Sales and Training since October 2006. From April 2006 to October 2006, she served as our Executive Director, U.S. Marketing and Aesthetic Market Development. From February 2003 to April 2006, Ms. Brodsky-Thalken was a principal at AAP, Inc. providing consulting services to the aesthetic medical device industry. From April 2002 to January 2003, Ms. Brodsky-Thalken served as Vice President, Sales of INAMED Corporation, a public medical device company. From February 1995 to March 2002, Ms. Brodsky-Thalken served as Regional Sales Director for INAMED Corporation. Ms. Brodsky-Thalken studied Biological Science at San Francisco State University.

Frank M. Fazio
Vice President, Marketing and International Markets

     Frank M. Fazio has been our Vice President, Marketing and International Markets since June 2006. From March 2005 to May 2006, Mr. Fazio served as Director, Market Development of INAMED Corporation, a public medical device company. From May 2002 to March 2005, Mr. Fazio served as Director, Facial Aesthetics of INAMED Corporation. From April 2001 to May 2002, Mr. Fazio was a Principal at AMC Consulting, providing consulting services to companies in the medical device industry. Mr. Fazio holds a B.S. in Molecular and Cellular Biology from the University of Arizona.

Karon J. Morell
Vice President, Regulatory and Quality Affairs

        Karon J. Morell has been our Vice President of Regulatory and Quality Affairs since December 2007. Before Artes Medical, she served as Vice President, Quality Assurance and Regulatory Affairs at IsoTis OrthoBiologics, a company that specializes in the research, development and manufacturing of bone grafts. Prior to IsoTis, she served as Vice President, Quality and Regulatory Affairs at Medegen MMS, a company that specializes in Class I & II devices for intravascular solutions. Previously, Ms. Morell held senior regulatory, quality and compliance positions at Nobel Biocare USA, Cardiac Science, Inc., and Newport Medical Instruments. Ms. Morell holds a B.A. in Business Management from Southern California University.

Artes Medical has retained the following firms to provide outside legal counsel and independent financial audits:

Corporate and Securities Counsel

DLA Piper US, LLP
Jeff Thacker, Esq.
4365 La Jolla Village Drive, Suite 1100
San Diego, CA 92121

Intellectual Property
Heller Ehrman, LLP
Kurt Kjelland, Esq.
4350 La Jolla Village Drive, 7th Floor
San Diego, CA 92122

Independent Auditors
Ernst & Young, LLP
Doug Regnier, Partner
4370 La Jolla Village Drive, 5th Floor
San Diego, CA 92122